For adults with stage 4-5 CKD, an HbA1c range of 6.7% to 7.1% may be optimal for reducing macrovascular and microvascular complications. In advanced chronic kidney disease (CKD) and diabetes (type 1 ...
Type 2 diabetes is a condition where the body struggles to manage blood sugar, and monitoring levels is key to staying ...
Active ingredient: Linagliptin 5 mg; tabs. Indication: Adjunct to diet and exercise in type 2 diabetes mellitus, as monotherapy or combination therapy. Pharmacology: Linagliptin is an inhibitor of DPP ...
Please provide your email address to receive an email when new articles are posted on . Mean glucose and J-index were the only CGM metrics associated with HbA1c in adults without diabetes. More ...
Credit: Shutterstock. The trial evaluated the efficacy and safety of empagliflozin and linagliptin in 175 patients 10 to less than 18 years of age with type 2 diabetes. Empagliflozin achieved a ...
A study analyzing the PIONEER trial data claims that orally administered semaglutide is highly effective in reducing glycated hemoglobin (HbA1c) and body weight in type 2 diabetes patients. The study ...